6 February 2013

Ceva records double digit growth for 3rd. successive year >

14% growth pushes sales beyond 600 M€ for first time

24 January 2013

Ceva presents a complete range of vector vaccines at IPE 2013 >

Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.

18 November 2012

Ceva announces scientific breakthrough with the launch of Vectormune® AI >

Vectormune® AI a new generation vaccine for the control of Avian Influenza.

29 October 2012

AXA Private Equity provides additional financing to support the development of Ceva >

AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.

6 September 2012

Ceva launches CARDALIS® for dogs with heart failure >

A powerful dual treatment in a single tablet

5 August 2012

The Perfect Pair is now available >

A great innovation in the protection against Newcastle and Gumboro Diseases

23 July 2012

Mid-year results : Innovation drives Ceva’s growth >

Double-digit growth confirms long term upward trend

15 July 2012

Ceva will launch the “Perfect Pair” for hatchery vaccination at World Poultry Congress >

Great innovation to be launched at 24th WPC in Brazil, August 5-9 2012

23 April 2012

Ceva organized 2nd Swine Reproduction Symposium >

Ceva Santé Animale gathers 150 experts from 18 countries in swine reproduction symposium

10 April 2012

Ceva sponsors 8th International Symposium on Avian Influenza >

Innovation in poultry vaccines and solutions reaches beyond animal health